No clue. If I could quantify probability of trial success. I'd be worth billions! Even the bigs guys regularly have trials that looked good in preclin, ph1 and ph2, fail phase 3 unexpectedly - after spending tens of millions and after having teams of excellent brains assess positive outcome. I believe this trial has a sound scientific foundation - is based on solid research pool, and has a good chance of success. But my belief doesn't mean much. We don't know until we know.
Market Data 
Markets 
AI
